Chemoinformaics analysis of o-Methylflavinantine
| Molecular Weight | 341.407 | nRot | 3 |
| Heavy Atom Molecular Weight | 318.223 | nRig | 21 |
| Exact Molecular Weight | 341.163 | nRing | 4 |
| Solubility: LogS | -3.479 | nHRing | 1 |
| Solubility: LogP | 1.705 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 53.0442 |
| nHD | 0 | BPOL | 30.8598 |
| QED | 0.846 |
| Synth | 4.464 |
| Natural Product Likeliness | 1.202 |
| NR-PPAR-gamma | 0.326 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.977 |
| Pgp-sub | 0.006 |
| HIA | 0.011 |
| CACO-2 | -4.943 |
| MDCK | 0.0000266 |
| BBB | 0.797 |
| PPB | 0.810495 |
| VDSS | 1.127 |
| FU | 0.208426 |
| CYP1A2-inh | 0.031 |
| CYP1A2-sub | 0.823 |
| CYP2c19-inh | 0.522 |
| CYP2c19-sub | 0.932 |
| CYP2c9-inh | 0.193 |
| CYP2c9-sub | 0.384 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.681 |
| CYP3a4-inh | 0.501 |
| CYP3a4-sub | 0.93 |
| CL | 9.841 |
| T12 | 0.642 |
| hERG | 0.051 |
| Ames | 0.028 |
| ROA | 0.444 |
| SkinSen | 0.15 |
| Carcinogencity | 0.382 |
| EI | 0.011 |
| Respiratory | 0.975 |
| NR-Aromatase | 0.81 |
| Antiviral | Yes |
| Prediction | 0.609819 |